Last Price
1.56
Today's Change
-0.165 (9.53%)
Day's Change
1.55 - 1.68
Trading Volume
153,526
Overview
Market Cap
0
Shares Outstanding
0
Avg Volume
0
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
0.00
Earnings Announcement
Previous Close
0.00
Open
0.00
Day's Range
0.0 - 0.0
Year Range
0.0 - 0.0
Trading Volume
0
Price Change Highlight
1 Day Change
5 Day Change
1 Month Change
3 Month Change
6 Month Change
Ytd Change
1 Year Change
3 Year Change
5 Year Change
10 Year Change
Max Change
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Health Information Services
Description:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Icents Group Holdings Berhad, a specialised construction company focused on cleanroom EPCC services for industries, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1192/Thumbnail__(9).png)
![[New IPO] A1 A.K. Koh Group Berhad, a well-established brand owner in the processed F&B industry, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1186/Thumbnail__(8).png)
![[New IPO] PMCK Berhad, a healthcare services provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1180/Thumbnail__(7).png)
Apps
Top Articles
1
Investment News
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
